School of Public Health and the Health and Risk Communication Lab, University of Haifa, Haifa, Israel.
Front Public Health. 2022 Mar 10;10:855468. doi: 10.3389/fpubh.2022.855468. eCollection 2022.
Because public healthcare workers (HCWs) are at the forefront of the battle against COVID-19, they must be able to provide vaccination information to their patients and respond to their anxieties and concerns. This research objectives were to (1) examine physicians' perceptions of how they received information about the Pfizer COVID-19 vaccine, their attitudes toward hesitant colleagues, and their own knowledge and self-efficacy in communicating information to their patients, and (2) to examine the public's perceptions of physicians' knowledge when recommending the COVID-19 vaccine to their patients. At the beginning of the vaccination campaign, a survey examined the attitudes of physicians in the Israeli public healthcare system ( = 295) regarding the Pfizer vaccine. In addition, the attitudes of a representative sample ( = 500) of the Israeli adult population (age 18+) were examined through interviews. Most of the participating physicians (81%) reported they had already been vaccinated or intended to be vaccinated. When asked about their reasons for vaccine hesitancy, 27% cited concerns about long-term side effects and doubts about the vaccine's effectiveness in preventing contagion. They cited system pressure and departmental norms as explanations for their eventual compliance. Moreover, they saw the system as less tolerant of hesitant physicians, while they themselves tend to be more tolerant. The results of the survey of the public showed that mostly young people (under 44) who tend to be critical believe that physicians do not have sufficient knowledge to make recommendations about the COVID-19 vaccine. The findings indicate that the health system should employ complete transparency in conveying the advantages and disadvantages of the COVID-19 vaccine to physicians. The system should be more tolerant of physicians' worries and concerns and grant legitimacy to their reservations and misgivings. Moreover, medical studies should reinforce physicians' immunological knowledge regarding vaccinations so they can help their patients make informed decisions.
由于公共卫生保健工作者（HCWs）是抗击 COVID-19 的第一线人员，他们必须能够向患者提供疫苗接种信息，并回应他们的焦虑和担忧。本研究的目的是：（1） 调查医生对其获取有关辉瑞 COVID-19 疫苗信息的看法、他们对犹豫不决的同事的态度，以及他们在向患者传达信息方面的知识和自我效能；（2） 调查公众对医生在向患者推荐 COVID-19 疫苗时的知识的看法。在疫苗接种运动开始时，一项调查研究了以色列公共医疗保健系统中医生（n=295）对辉瑞疫苗的态度。此外，还通过访谈调查了以色列成年人口（18 岁以上）的代表性样本（n=500）的态度。大多数参与的医生（81%）报告说他们已经接种了疫苗或打算接种疫苗。当被问及他们对疫苗犹豫不决的原因时，27%的人提到对长期副作用的担忧，以及对疫苗预防传染有效性的怀疑。他们将系统压力和部门规范作为他们最终遵守的解释。此外，他们认为系统对犹豫不决的医生容忍度较低，而他们自己则更宽容。公众调查的结果表明，大多数年轻人（44 岁以下）对医生是否有足够的知识来推荐 COVID-19 疫苗持批评态度。研究结果表明，卫生系统应该在向医生传达 COVID-19 疫苗的优缺点方面保持完全透明。系统应该对医生的担忧更加宽容，并承认他们的保留意见和疑虑是合理的。此外，医学研究应该加强医生对疫苗接种的免疫学知识，以便他们能够帮助患者做出明智的决定。
